ALKERAN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Turkey.

Active ingredients

The drug ALKERAN contains one active pharmaceutical ingredient (API):

1	Melphalan UNII Q41OR9510P - MELPHALAN
	Melphalan is a bifunctional alkylating agent. Formation of carbonium intermediates from each of the two bis-2-chloroethyl groups enables alkylation through covalent binding with the 7-nitrogen of guanine on DNA, cross-linking the two DNA strands and thereby preventing cell replication.
	Read more about Melphalan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ALKERAN	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AA03	Melphalan	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2547C
BR	Câmara de Regulação do Mercado de Medicamentos	505617060041517, 505617060041617
CA	Health Products and Food Branch	00004715, 02087286
EE	Ravimiamet	1004410, 1006434, 1708770
FI	Lääkealan turvallisuus- ja kehittämiskeskus	125125
FR	Base de données publique des médicaments	68262525, 68708664
HK	Department of Health Drug Office	03792, 37994
IE	Health Products Regulatory Authority	11193
IL	מִשְׂרַד הַבְּרִיאוּת	1069
JP	医薬品医療機器総合機構	4219002F1034, 4219403F1023
LT	Valstybinė vaistų kontrolės tarnyba	1000049, 1006932
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	62511
NL	Z-Index G-Standaard	13669249
NL	Z-Index G-Standaard, PRK	35254, 65641
NZ	Medicines and Medical Devices Safety Authority	10081, 309
PL	Rejestru Produktów Leczniczych	100003930, 100344736
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W58865001, W58865002
SG	Health Sciences Authority	11822P, 11873P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699874080021
US	FDA, National Drug Code	52609-0001
ZA	Health Products Regulatory Authority	27/26/0506, 27/34/0507, H/26/2744